Stereotaxis - the road to $5.5 Bn - Episode 2 - David Fischel, CEO at Stereotaxis
The Crux of Medtech · The Crux of Medtech
Audio is streamed directly from the publisher (anchor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
It’s Episode 2 of The Surgibots Podcast!
On this episode, your host Henry Norton was joined by David Fischel, the CEO of Stereotaxis, to talk about the company’s latest innovations.
Stereotaxis is a publicly traded company who make robots that are used for minimally invasive heart surgery. Their framework is built on an ecosystem that is set to change innovation in the industry.
David himself came to the company from the finance world, where he specialised as a medical devices investor. His recent shift into operations as the company’s CEO has been supported by an unusual compensation package that we dive into in this episode.
Tune in to learn more about the future of surgical robotics!